1. Pharmacological properties and derivatives of shikonin—A review in recent years
   Chuanjie Guo et al, 2019, Pharmacological Research CrossRef
2. Shikonin inhibits cancer cell cycling by targeting Cdc25s
   Shoude Zhang et al, 2019, BMC Cancer CrossRef
3. Pharmacological Significance of Boraginaceae with Special Insights into Shikonin and Its Potential in the Food Industry
   Shweta Gautam et al, 2024, Foods CrossRef
4. Shikonin derivatives for cancer prevention and therapy
   Joelle C. Boulos et al, 2019, Cancer Letters CrossRef
5. JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia
   Haidée Aranda-Tavío et al, 2021, Biomedicine & Pharmacotherapy CrossRef
6. Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction
   Fangfang Wang et al, 2020, Frontiers in Pharmacology CrossRef
7. Synthesis, biological function and evaluation of Shikonin in cancer therapy
   Fangfang Wang et al, 2019, Fitoterapia CrossRef
8. Shikonin Derivatives Inhibit Inflammation Processes and Modulate MAPK Signaling in Human Healthy and Osteoarthritis Chondrocytes
   Birgit Lohberger et al, 2022, International Journal of Molecular Sciences CrossRef
9. Shikonin Derivatives from Onsoma visianii Decrease Expression of Phosphorylated STAT3 in Leukemia Cells and Exert Antitumor Activity
   Zeljko Todorovic et al, 2021, Nutrients CrossRef
10. The anti-leukemia activity and mechanisms of shikonin: a mini review
    Han Dong et al, 2023, Frontiers in Pharmacology CrossRef
11. Two novel 1,4‑naphthoquinone derivatives induce human gastric cancer cell apoptosis and cell cycle arrest by regulating reactive oxygen species‑mediated MAPK/Akt/STAT3 signaling pathways
    Hao Wang et al, 2019, Molecular Medicine Reports CrossRef
12. Recent advances in shikonin for the treatment of immune-related diseases: Anti-inflammatory and immunomodulatory mechanisms
    Yimeng Guo et al, 2023, Biomedicine & Pharmacotherapy CrossRef
13. Dexmedetomidine Alleviates Lipopolysaccharide-Induced Hippocampal Neuronal Apoptosis via Inhibiting the p38 MAPK/c-Myc/CLIC4 Signaling Pathway in Rats
    Yongping Chen et al, 2021, Molecular Neurobiology CrossRef
14. Shikonin Suppresses Cell Tumorigenesis in Gastric Cancer Associated with the Inhibition of c-Myc and Yap-1
    Fei Zhang et al, 2024, Combinatorial Chemistry & High Throughput Screening CrossRef
15. Shikonin inhibits the proliferation of cervical cancer cells via FAK/AKT/GSK3β signalling
    Ziyan Xu et al, 2022, Oncology Letters CrossRef
16. Shikonin derivatives cause apoptosis and cell cycle arrest in human chondrosarcoma cells via death receptors and MAPK regulation
    Birgit Lohberger et al, 2022, BMC Cancer CrossRef
17. Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways
    József Király et al, 2023, Molecules CrossRef
18. MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
    Ka Iong Chan et al, 2024, Aging and disease CrossRef
19. Shikonin Induced Program Cell Death through Generation of Reactive Oxygen Species in Renal Cancer Cells
    Ming-Feng Tsai et al, 2021, Antioxidants CrossRef
20. In vitro mass production, chemical modification, and cytotoxicity of shikonin derivatives on breast cancer cells
    Melike Tepe et al, 2023, Industrial Crops and Products CrossRef
21. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
    Hua Luo et al, 2019, Chinese Medicine CrossRef
22. Research progress in mechanism of anticancer action of shikonin targeting reactive oxygen species
    Ke Qi et al, 2024, Frontiers in Pharmacology CrossRef
23. Anti-cancer Research on Arnebiae radix-derived Naphthoquinone in Recent Five Years
    Shengjun Ma et al, 2022, Recent Patents on Anti-Cancer Drug Discovery CrossRef